Daiichi Sankyo Company, Limited (4568.T)
JPY 4342.0
(-0.02%)
JPY 4342.0
(-0.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 211.58 Billion JPY | 54.27% |
| 2022 | 120.58 Billion JPY | 65.12% |
| 2021 | 73.02 Billion JPY | 14.47% |
| 2020 | 63.79 Billion JPY | -54.04% |
| 2019 | 138.8 Billion JPY | 65.82% |
| 2018 | 83.7 Billion JPY | 9.73% |
| 2017 | 76.28 Billion JPY | -14.22% |
| 2016 | 88.92 Billion JPY | -31.81% |
| 2015 | 130.41 Billion JPY | 75.23% |
| 2014 | 74.42 Billion JPY | -33.28% |
| 2013 | 111.55 Billion JPY | 10.98% |
| 2012 | 100.51 Billion JPY | 2.36% |
| 2011 | 98.2 Billion JPY | -19.6% |
| 2010 | 122.14 Billion JPY | 27.89% |
| 2009 | 95.5 Billion JPY | 7.47% |
| 2008 | 88.87 Billion JPY | -43.33% |
| 2007 | 156.82 Billion JPY | 15.05% |
| 2006 | 136.31 Billion JPY | -11.9% |
| 2005 | 154.72 Billion JPY | 82.19% |
| 2004 | 84.92 Billion JPY | -11.12% |
| 2003 | 95.55 Billion JPY | 19.69% |
| 2002 | 79.83 Billion JPY | -1.01% |
| 2001 | 80.64 Billion JPY | -8.13% |
| 2000 | 87.78 Billion JPY | -38.48% |
| 1999 | 142.71 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 93.66 Billion JPY | 0.74% |
| 2024 Q1 | 92.97 Billion JPY | 456.96% |
| 2023 Q4 | 16.69 Billion JPY | -83.22% |
| 2023 FY | 186.01 Billion JPY | 54.27% |
| 2023 Q1 | 44.03 Billion JPY | 772.14% |
| 2023 Q2 | 51.03 Billion JPY | 15.9% |
| 2023 Q3 | 99.48 Billion JPY | 94.95% |
| 2022 FY | 120.58 Billion JPY | 65.12% |
| 2022 Q3 | 31.55 Billion JPY | -48.45% |
| 2022 Q1 | 34.38 Billion JPY | 167.75% |
| 2022 Q2 | 61.19 Billion JPY | 77.99% |
| 2022 Q4 | -6.55 Billion JPY | -120.76% |
| 2021 Q3 | 39.03 Billion JPY | 0.15% |
| 2021 Q4 | -50.74 Billion JPY | -230.02% |
| 2021 FY | 73.02 Billion JPY | 14.47% |
| 2021 Q1 | 45.76 Billion JPY | 278.31% |
| 2021 Q2 | 38.97 Billion JPY | -14.85% |
| 2020 Q1 | 34.12 Billion JPY | 303.34% |
| 2020 FY | 63.79 Billion JPY | -54.04% |
| 2020 Q2 | 24.34 Billion JPY | -28.66% |
| 2020 Q3 | 30.99 Billion JPY | 27.33% |
| 2020 Q4 | -25.66 Billion JPY | -182.81% |
| 2019 Q1 | 56.99 Billion JPY | 526.05% |
| 2019 FY | 138.8 Billion JPY | 65.82% |
| 2019 Q4 | -16.78 Billion JPY | -124.17% |
| 2019 Q3 | 69.41 Billion JPY | 137.98% |
| 2019 Q2 | 29.17 Billion JPY | -48.82% |
| 2018 FY | 83.7 Billion JPY | 9.73% |
| 2018 Q2 | 28.06 Billion JPY | -6.19% |
| 2018 Q1 | 29.91 Billion JPY | 276.57% |
| 2018 Q4 | -13.37 Billion JPY | -134.21% |
| 2018 Q3 | 39.09 Billion JPY | 39.31% |
| 2017 Q3 | 44.46 Billion JPY | 424.07% |
| 2017 Q2 | 8.48 Billion JPY | -78.93% |
| 2017 Q1 | 40.27 Billion JPY | 201.24% |
| 2017 Q4 | -16.94 Billion JPY | -138.1% |
| 2017 FY | 76.28 Billion JPY | -14.22% |
| 2016 Q2 | 26.01 Billion JPY | -44.95% |
| 2016 Q4 | -39.77 Billion JPY | -171.75% |
| 2016 Q1 | 47.25 Billion JPY | 336.28% |
| 2016 FY | 88.92 Billion JPY | -31.81% |
| 2016 Q3 | 55.43 Billion JPY | 113.09% |
| 2015 FY | 130.41 Billion JPY | 75.23% |
| 2015 Q4 | -20 Billion JPY | -137.45% |
| 2015 Q1 | 49.12 Billion JPY | 237.02% |
| 2015 Q2 | 47.88 Billion JPY | -2.54% |
| 2015 Q3 | 53.4 Billion JPY | 11.54% |
| 2014 Q2 | 39.38 Billion JPY | 33.81% |
| 2014 FY | 74.42 Billion JPY | -33.28% |
| 2014 Q4 | -35.85 Billion JPY | -186.47% |
| 2014 Q3 | 41.46 Billion JPY | 5.29% |
| 2014 Q1 | 29.43 Billion JPY | 156.54% |
| 2013 Q2 | 34.9 Billion JPY | 68.15% |
| 2013 Q3 | 44.41 Billion JPY | 27.24% |
| 2013 Q4 | 11.47 Billion JPY | -74.17% |
| 2013 FY | 111.55 Billion JPY | 10.98% |
| 2013 Q1 | 20.75 Billion JPY | 197.58% |
| 2012 Q2 | 24.55 Billion JPY | -24.49% |
| 2012 Q3 | 36.46 Billion JPY | 48.49% |
| 2012 Q4 | 6.97 Billion JPY | -80.87% |
| 2012 FY | 100.51 Billion JPY | 2.36% |
| 2012 Q1 | 32.52 Billion JPY | 413.74% |
| 2011 Q2 | 18.71 Billion JPY | -56.97% |
| 2011 Q3 | 29.68 Billion JPY | 58.63% |
| 2011 Q4 | 6.33 Billion JPY | -78.67% |
| 2011 FY | 98.2 Billion JPY | -19.6% |
| 2011 Q1 | 43.48 Billion JPY | 2775.79% |
| 2010 FY | 122.14 Billion JPY | 27.89% |
| 2010 Q3 | 30.52 Billion JPY | 5.09% |
| 2010 Q2 | 29.04 Billion JPY | -52.43% |
| 2010 Q1 | 61.06 Billion JPY | 1020.8% |
| 2010 Q4 | 1.51 Billion JPY | -95.05% |
| 2009 Q1 | 26.76 Billion JPY | 391.47% |
| 2009 FY | 95.5 Billion JPY | 7.47% |
| 2009 Q4 | 5.44 Billion JPY | -86.11% |
| 2009 Q3 | 39.21 Billion JPY | 62.81% |
| 2009 Q2 | 24.08 Billion JPY | -10.02% |
| 2008 Q2 | 21.61 Billion JPY | 0.0% |
| 2008 FY | 88.87 Billion JPY | -43.33% |
| 2008 Q3 | 36.44 Billion JPY | 68.63% |
| 2008 Q4 | -9.18 Billion JPY | -125.2% |
| 2007 FY | 156.82 Billion JPY | 15.05% |
| 2006 FY | 136.31 Billion JPY | -11.9% |
| 2005 FY | 154.72 Billion JPY | 82.19% |
| 2004 FY | 84.92 Billion JPY | -11.12% |
| 2003 FY | 95.55 Billion JPY | 19.69% |
| 2002 FY | 79.83 Billion JPY | -1.01% |
| 2001 FY | 80.64 Billion JPY | -8.13% |
| 2000 FY | 87.78 Billion JPY | -38.48% |
| 1999 FY | 142.71 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 95.84 Billion JPY | -120.768% |
| Astellas Pharma Inc. | 124.6 Billion JPY | -69.806% |
| Chugai Pharmaceutical Co., Ltd. | 439.17 Billion JPY | 51.821% |
| Ono Pharmaceutical Co., Ltd. | 163.1 Billion JPY | -29.727% |
| Santen Pharmaceutical Co., Ltd. | 38.54 Billion JPY | -448.995% |
| JCR Pharmaceuticals Co., Ltd. | 7.53 Billion JPY | -2709.187% |
| Otsuka Holdings Co., Ltd. | 139.61 Billion JPY | -51.554% |
| Perseus Proteomics Inc. | -894.72 Million JPY | 23748.278% |